To explore the short-term clinical effects of da Vinci robot assisted colorectal cancer operation based on enhanced recovery after surgery (ERAS).

Ninety colorectal cancer patients who underwent da Vinci robot assisted colorectal cancer operation from February 2020 to April 2021 at the Second Surgery Department, the Fourth Hospital of Hebei Medical University were included and retrospectively analyzed, including 47 patients treated based on ERAS (ERAS group), and 43 who were treated traditionally (traditional group). ERAS measures included preoperative, intraoperative, and postoperative core measures. General condition, postoperative recovery, postoperative pain score, and incidence of postoperative complications were compared between the two groups. SPSS 26.0 software was used for statistical analyses.

There were no significant differences in age, gender, BMI, primary tumor, ASA score, histological classification, or preoperative TNM stage between the two groups (P＞0.05). The time to ambulation [(1.9±0.8) d vs (2.6±0.9) d], time to first exhaust [(2.1±0.8) d vs (2.7±0.8) d], time to intake of liquid food [(1.8±0.7) d vs (2.8±0.8) d], and hospital stay [(6.7±1.1) d vs (8.0±1.6) d] were significantly shorter in the ERAS group than in the traditional group (P＜0.001). The postoperative VAS pain score in the ERAS group was significantly lower than that of the traditional group (F=19.837, P＜0.001). The incidences of postoperative urinary retention (2.1% vs 6.3%, P=0.047) and overall complications (12.8% vs 32.6%, P=0.024) in the ERAS group were significantly lower than that of the traditional group (P＜0.05).

The implement of ERAS in perioperative management of patients undergoing da Vinci robot assisted colorectal cancer operation is safe and effective, which has appreciated clinical value.